Purpose: To quantify retinal capillary density and determine its correlation with visual acuity in patients with birdshot chorioretinopathy (BCR).
B
irdshot chorioretinopathy (BCR), first described in 1980 by Ryan and Maumenee, is a chronic bilateral disease, commonly affecting middle-aged, otherwise healthy patients. 1, 2 Symptoms typically include floaters, nyctalopia, photopsias, decreased color vision, and blurred vision. 2, 3 Although the pathologic mechanisms underlying BCR are not fully understood, it is generally considered an autoimmune disorder. 4 Clinically, it is characterized by bilateral yellowwhite choroidal lesions, mild vitreous inflammation as well as retinal vasculitis and arteriolar narrowing, and is highly associated with the HLA-A29 haplotype. It has been hypothesized that inflammation in BCR evolves independently in the choroid and retinal vessels. 5, 6 Sequelae of the disease include diffuse photoreceptor loss, cystoid macular edema (50%), epiretinal membranes (ERMs) (8%), and choroidal neovascularization (5%-7.5%). 2, 7 Fluorescein angiography is considered the gold standard imaging modality for retinal vascular manifestation of BCR, highlighting findings of vasculitis, subclinical retinal capillary occlusion, or vascular hyperpermeability. 8, 9 As it is a strictly two-dimensional imaging modality, it is not possible to be aware of the different retinal capillary plexuses on fluorescein angiography, precluding the distinction of ischemia at different levels within the retina. 10 Furthermore, although fluorescein angiography has the advantage of imaging dye leakage as evidence of breakdown of the bloodretinal barrier, this feature also carries the disadvantage of obscuring underlying anatomical detail.
With this in mind, we chose to use the new and noninvasive optical coherence tomography angiography (OCTA), a functional extension of conventional optical coherence tomography (OCT). Optical coherence tomography angiography shows the retinal and choroidal vasculature by detection of blood flow within the vessels, while also depicting the retinal microstructure three dimensionally (like conventional OCT). Previous studies have used OCTA to qualitatively characterize BCR eyes; however, significant questions remain regarding the quantitative changes at the different retinal capillary plexuses and their impact on visual acuity (VA). 11 The aim of this study was to use OCTA to quantify the alterations in the different retinal capillary plexuses and their impact on VA in patients with BCR.
Methods

Study Participants
The study protocol and procedures adhered to the ethics tenets of the Declaration of Helsinki and were approved by Northwestern University's Institutional Review Board. Informed consent was obtained from each participant before inclusion in this retrospective observational cross-sectional study. Healthy control participants and participants diagnosed with BCR were recruited at the Department of Ophthalmology of the Feinberg School of Medicine at Northwestern University, Chicago, IL. Inclusion criteria for the BCR cohort were consistent with the international consensus conference research criteria for the diagnosis of BCR. 12 All patients were HLA-A29 positive. Eyes were not included in this study if they did not meet the criteria, had opacified ocular media, or low quality imaging preventing a detailed analysis of retinal capillary plexuses. All patients had been diagnosed by a single uveitis specialist (D.A.G.) and were followed regularly for BCR at Northwestern University including best-corrected VA (BCVA) testing, complete ocular examination, OCT imaging, color fundus photography, electroretinography, and Goldmann visual fields.
Imaging
For OCTA imaging and evaluation, a commercial spectral domain OCT device (RTVue-XR Avanti; Optovue, Inc, Fremont, CA) was used. The OCT uses a light beam with a center wavelength of 840 nm and a full-width half maximum of 45 nm operating at an axial scan rate of 70.000 A-scans per second. The OCTA volume scans consisted of 304 · 304 · 512 voxels and were acquired in 2.9 seconds. For the purpose of this study, angiographic en face OCT measuring 3 mm · 3 mm (x · y) were evaluated using the incorporated Angiovue software. For detection of blood flow, the device acquires two consecutive B-scans at the same position to differentiate between bulk tissue and fluctuating particles (mostly erythrocytes in the blood stream). The machine uses split-spectrum amplitudedecorrelation angiography to improve the performance of the vessel segmentation algorithm. For the purpose of selecting images with a high enough image quality, we used the signal strength index, a measure automatically displayed with every volume scan. Images with a signal strength index below 50 were not included in our analysis.
Assessment of Capillary Density, Retinal Thickness, and Foveal Avascular Zone
We used the integrated analytics software (version 2016.1.0.26) of the Angiovue device to evaluate the vessel density, retinal thickness, and foveal avascular zone (FAZ). We used the preset segmentation of the superficial capillary plexus (SCP), where the inner and outer boundaries are set 3 mm posterior to the internal limiting membrane and 15 mm posterior to the inner plexiform layer (IPL), respectively. In eyes with an ERM, the internal boundary was set 3 mm posterior to the ERM and not the internal limiting membrane. However, because the posterior boundary of the segmentation was dependent on the position of the IPL, the slab included the entire SCP and manual adjustment of the anterior boundary was not necessary.
For the deep capillary plexus (DCP), the inner and outer boundaries are set 15 mm posterior to the IPL and 70 mm posterior to the IPL, respectively. To evaluate the vasculature of the entire retinal thickness, the inner boundary was set at 3 mm posterior to the internal limiting membrane (in cases with an ERM this was 3 mm posterior to the ERM), and the outer boundary was manually set at the outer nuclear layer, posterior to the DCP. Depending on the retinal anatomy, the offset from the IPL differed individually, however, was always placed within the outer nuclear layer and anterior to the hyperreflective retinal pigment epithelium. We assessed SCP, DCP, and full retinal vessel densities for the whole en face image (3 · 3 mm) as well as for the parafoveal area (ring with a diameter of 3 mm of the outer circle and a diameter of 1 mm of the inner circle).
The FAZ area was measured using the nonflow detection algorithm integrated in the analysis software. By clicking into the center of the FAZ in the en face angiographic image of the SCP, the software automatically extends the measured area to the vessels surrounding the FAZ (Figure 1 ).
Retinal thickness was automatically measured as the distance between the internal limiting membrane and the retinal pigment epithelium for the foveal (circle with a diameter of 1 mm) and parafoveal areas.
Statistics
We used IBM SPSS statistics version 21 (IBM SPSS Statistics, IBM Corporation, Chicago, IL). The Shapiro-Wilk test was used to test for normal distribution of the parameters. We used a Mann-Whitney U test to compare the FAZ area, retinal thickness, and the vessel densities of the SCP, DCP, and full retina between the BCR and the control group. We used Spearman correlation analysis to study the correlations between VA and the following parameters: BCR disease duration, capillary density, FAZ area, and retinal thickness. For these analyses, VA was converted from Snellen to the logarithm of the minimal angle of resolution.
Results
Our study included 74 eyes of 42 study participants (28 women, 14 men) with a mean age of 58 years (±9 [SD]). Overall demographic and clinical characteristics are presented in Table 1 .
Representative examples of retinal capillary density and FAZ area are presented in Figures 2-4.
Patients with BCR had a mean disease duration of 6 years (±3.5 SD). Twenty-four eyes had an ERM, eight eyes had cystoid macular edema, two eyes had a choroidal neovascularization, and one eye had subretinal fluid associated with cystoid macular edema. All except for two study patients with BCR (three study eyes) were receiving either local or systemic therapy including corticosteroids as well as other immunomodulators (Table 1) .
Superficial capillary plexus, DCP, and full retinal vessel density were significantly lower in the BCR group compared with healthy controls. A significant difference was observed in the parafoveal retinal thickness between BCR and healthy controls but not in foveal retinal thickness. Details are presented in Table 2 .
The vessel densities of the SCP, DCP, and full retina showed a significant (negative) correlation with BCVA (logarithm of the minimal angle of resolution) in patients with BCR. In the control eyes, there was no significant correlation between BCVA and any of the following parameters: vessel density, FAZ area, foveal, and parafoveal retinal thickness (Table 3) .
Discussion
In this study, we used OCTA to quantitatively analyze vessel densities of the retinal capillary plexuses in eyes with BCR and assess their correlation with VA. We found that the SCP and DCP vessel densities were significantly reduced in eyes with BCR when compared with an age-matched control group (Table 2 ). Vessel density in the different capillary plexuses was significantly associated with VA in patients with BCR. This was not the case in the healthy control group (Table 3 ). The FAZ area and foveal retinal thickness were not significantly different between BCR and healthy controls. The parafoveal retinal thickness, however, was significantly thinner in the BCR group (Table 2 ). There were no significant correlations in either the BCR or healthy control groups between VA and any of the following parameters: FAZ area, foveal, or parafoveal retinal thickness (Table 3) .
The different retinal vascular plexuses show a nonuniform capillary distribution, which might be attributed to the metabolic demands of adjacent retinal tissue. 13 It has been hypothesized that different vascular diseases could affect capillary networks differently, prompting us to separately examine the SCP and DCP in our study. 14, 15 In a recent study, de Carlo et al 11 used OCTA in a series of four patients with BCR to show flow-void areas in the choroid in birdshot lesions and changes in the full retinal capillary network. The retinal capillary changes detected in their study included abnormally tortuous vessels, capillary loops, focal dilatations, and an increased intercapillary space, features typically seen in later stages of vasculitis. 11, 16 This meticulous evaluation of microangiographic changes in the retina is, however, subjective in nature and would be challenging and time consuming to perform in clinical practice as well as for the larger number of eyes and for the different retinal capillary plexuses. Therefore, we decided to use a quantitative and automated approach to assess microvascular damage. In our study, capillary density in the SCP, DCP, and the full retina was significantly decreased in the BCR group, suggesting that microvascular inflammation and subsequent capillary closure are present throughout the retinal vasculature and not confined to a particular network in this disease.
In a histopathological study of BCR eyes, Gaudio et al 6 showed foci of lymphocytic aggregations along retinal vessels, but did not specify in which layer of the retina these were most numerous. They hypothesized that a progression from these perivascular lymphocytic infiltrations to ischemia of the inner retina might be expected in patients with BCR in later stages of the disease. In our series, we found a significant decrease of the retinal capillary density as well as retinal thickness in the parafoveal area in eyes of patients with BCR (with a mean disease duration of 6 years), which seems to support their hypothesis. Recently, Agrawal et al 17 measured retinal vascular calibers in patients with BCR and reported significantly impaired calibers only in the retinal venules compared with a healthy control group. This finding suggests that microvascular inflammatory damage in BCR is primarily present in the venous arm. anti-VEGF, anti-vascular endothelial growth factor; CME, cystoid macular edema; CNV, choroidal neovascularization; IMT, immunomodulatory therapy; IVTA, intravitreal triamcinolone acetonide injection; logMAR, logarithm of the minimal angle of resolution; PST triamcinolone acetonide, posterior subtenon injection of triamcinolone acetonide; SRF, subretinal fluid. Foveal retinal thickness was not significantly different between the BCR and healthy control group in our study, nor was the FAZ area. However, parafoveal retinal thickness was significantly decreased in the BCR eyes. Retinal thinning in this area may be caused by retinal atrophy secondary to capillary loss in the macula. Because the fovea contains no inner retinal layers and, therefore, no capillary network, the foveal zone (circle with a 1 mm diameter) may be less susceptible to retinal vasculitis and subsequent retinal atrophy. The choroidal perfusion could be sufficiently robust to support the fovea, which would explain the nonsignificant difference in foveal retinal thickness between the groups in this study. Furthermore, the presence of intraretinal cysts and/or an ERM is likely to distort the foveal contour, resulting in thickening of the fovea in the BCR eyes. In fact, when we compared the healthy controls and BCR eyes (excluding eight eyes with cystoid macular edema), the mean foveal thickness in both groups was surprisingly similar (259.9 ± 31.3 vs. 259.9 ± 32.4 mm). An important consideration, however, is that diffuse retinal thickening without the presence of intraretinal cysts may be present in the fovea secondary to subtle capillary leakage in BCR. The actual foveal retinal tissue thickness may, therefore, be thinner in patients with BCR than in healthy controls but this might not be obvious due to overall retinal (noncystic) swelling.
The BCVA was significantly correlated with capillary density in the SCP, the DCP, and the full retina in the BCR group. In the healthy control group, however, we did not observe a significant correlation between VA and retinal capillary densities. Previous studies in BCR have shown disruption of photoreceptor bands and outer retinal atrophy on OCT associated with vision loss. 2, [18] [19] [20] [21] An association of photoreceptor layer disruption on OCT with retinal vasculitis has been suggested. 21 These findings might be explained by the important role of the DCP in maintaining a functional outer retinal metabolism. Recently, our group has shown an association between DCP nonperfusion and photoreceptor disruption in patients with diabetic macular ischemia, highlighting the important role of the DCP for oxygen needs of the outer retina. 14 In BCR, the correlation between vessel density and VA may be caused by one of the following mechanisms or a combination of these. Since the plexiform layers of the retina are known to be highly metabolizing regions and dependent on sufficient oxygen supply, retinal vascular impairment could lead to ischemia and subsequent dysfunction of signal transmission within the parafoveal inner retina. 22 Another possibility is that, although primarily nourished by the choroidal vasculature, foveal cones may be dependent on lateral diffusion of oxygen from the surrounding retinal capillary plexuses. 23 Finally, it is plausible that there is no direct cause-and-effect relationship between VA and retinal vessel density. In this scenario, retinal vessel density may be a significant, but indirect biomarker for global retinal damage including photoreceptor compromise, caused by the underlying inflammatory mediators in BCR. We cannot rule out that choriocapillaris and choroidal changes, which we did not assess in this study, could account for photoreceptor and VA deterioration in patients with BCR. Previous studies, however, based on indocyanine green angiography, OCT, and histopathology have suggested that there may be differential inflammatory involvement of the retina and choroid in BCR. 5, 6, 20 Furthermore, current spectral domain-OCT-based OCTA devices have limited penetration depth into the choroid, making an accurate evaluation of miniscule abnormalities particularly challenging. 11 For these reasons, we think that future studies using swept-source OCT-based OCTA operating at longer wavelengths are necessary to comprehensively investigate the relationship between retinal and choroidal vascular damage.
There was no significant difference in the FAZ area between the two groups. This finding stands in contrast to other retinal vascular diseases such as diabetic retinopathy or retinal vein occlusion, where enlargement of the FAZ is a typical finding that is The foveal area was defined as a circle with a diameter of 1 mm centered on the fovea. The parafoveal area was defined as a ring with a diameter of 3 mm surrounding the foveal area.
*Statistically significant differences between the groups. The foveal area was defined as a circle with a diameter of 1 mm centered on the fovea. The parafoveal area was defined as a ring with a diameter of 3 mm surrounding the foveal area.
*Statistically significant correlations. logMAR, logarithm of the minimal angle of resolution.
associated with structural damage to inner and outer retinal layers. 14, 24 The FAZ area in the general population, however, is highly variable, which may reduce the predictive value of this parameter for an individual patient. 25 Using the implemented software of the OCTA instrument for automated measurement of the FAZ, we observed FAZ area sizes in both groups that were similar to a recent report of healthy eyes by Shahlaee et al, 26 who used a manual method for FAZ delineation in OCTA images. Given that the control and BCR groups were age matched in our study, we do not believe that age could have had any role as a potential confounder in the correlation between FAZ area and VA, a finding previously shown in eyes with retinal ischemic vascular disease. 24 We are aware of certain limitations of this study. The cross-sectional observational study design limited our observations to only one point in time within the disease process. As well, the study did not stratify patients with BCR based on disease severity, duration, or control. Larger, longitudinal studies would allow for better understanding of the vascular pathology and the chain of events that eventually lead to retinal damage and visual impairment, but the rarity of this diagnosis may make this a difficult goal to achieve. Because of the small field of view of the OCTA device (and focusing on correlations with VA), we only analyzed vessel densities in the macula in our study. We predict that similar vascular damage occurs outside the arcades, given electroretinographic findings and Goldmann visual field test results that are suggestive of global retinal functional changes, 7 but repeated OCTA measurements outside the macula are necessary to confirm this theory. Furthermore, exclusion of OCTA scans of low quality and scans with severe motion artifacts may have led to exclusion of the most severe cases of BCR. Strengths of our study include a rather large number of study eyes, an age-matched control group, and automated analyses.
In conclusion, our study showed decreased capillary density in all retinal vascular plexuses in eyes with BCR compared with healthy controls, a finding which was significantly correlated with BCVA in BCR. The FAZ area was not different in eyes with BCR compared with healthy controls and did not correlate with vision. Retinal capillary density measured automatically by OCTA might be a promising new parameter to monitor disease progression during follow-up and management of BCR and may be a useful biomarker in future longitudinal studies.
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